These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 23094440)
1. [PARP inhibitors and their role in the therapy of triple-negative metastatic breast cancer]. Kozioł M; Püsküllüoglu M; Zygulska A Przegl Lek; 2012; 69(6):265-70. PubMed ID: 23094440 [TBL] [Abstract][Full Text] [Related]
2. Directed therapy of subtypes of triple-negative breast cancer. Carey LA Oncologist; 2010; 15 Suppl 5():49-56. PubMed ID: 21138955 [TBL] [Abstract][Full Text] [Related]
3. Differential anti-proliferative activities of poly(ADP-ribose) polymerase (PARP) inhibitors in triple-negative breast cancer cells. Chuang HC; Kapuriya N; Kulp SK; Chen CS; Shapiro CL Breast Cancer Res Treat; 2012 Jul; 134(2):649-59. PubMed ID: 22678161 [TBL] [Abstract][Full Text] [Related]
4. Iniparib in metastatic triple-negative breast cancer. Domagala P; Lubinski J; Domagala W N Engl J Med; 2011 May; 364(18):1780; author reply 1781. PubMed ID: 21542760 [No Abstract] [Full Text] [Related]
5. Directed therapy of subtypes of triple-negative breast cancer. Carey LA Oncologist; 2011; 16 Suppl 1():71-8. PubMed ID: 21278443 [TBL] [Abstract][Full Text] [Related]
7. Response of subtype-specific human breast cancer-derived cells to poly(ADP-ribose) polymerase and checkpoint kinase 1 inhibition. Shibata H; Miuma S; Saldivar JC; Huebner K Cancer Sci; 2011 Oct; 102(10):1882-8. PubMed ID: 21707865 [TBL] [Abstract][Full Text] [Related]
8. Triple-negative breast cancer and poly(ADP-ribose) polymerase inhibitors. Park Y; Moriyama A; Kitahara T; Yoshida Y; Urita T; Kato R Anticancer Agents Med Chem; 2012 Jul; 12(6):672-7. PubMed ID: 22263793 [TBL] [Abstract][Full Text] [Related]
9. Promising therapeutic options in triple-negative breast cancer. Bilici A; Arslan C; Altundag K J BUON; 2012; 17(2):209-22. PubMed ID: 22740196 [TBL] [Abstract][Full Text] [Related]
10. Molecular stratification of triple-negative breast cancers. Perou CM Oncologist; 2011; 16 Suppl 1():61-70. PubMed ID: 21278442 [TBL] [Abstract][Full Text] [Related]
11. Novel treatment approaches for triple-negative breast cancer. Telli ML; Ford JM Clin Breast Cancer; 2010; 10 Suppl 1():E16-22. PubMed ID: 20587403 [TBL] [Abstract][Full Text] [Related]
12. Molecular stratification of triple-negative breast cancers. Perou CM Oncologist; 2010; 15 Suppl 5():39-48. PubMed ID: 21138954 [TBL] [Abstract][Full Text] [Related]
13. Targeted therapy for triple-negative breast cancer: where are we? Duffy MJ; McGowan PM; Crown J Int J Cancer; 2012 Dec; 131(11):2471-7. PubMed ID: 22581656 [TBL] [Abstract][Full Text] [Related]
14. Triple-negative breast cancer in focus: from biology to novel therapeutics. Editorial. Piccart MJ Ann Oncol; 2012 Aug; 23 Suppl 6():vi5-6. PubMed ID: 23012303 [No Abstract] [Full Text] [Related]
15. Poly(ADP-ribose) polymerase inhibitors in triple-negative breast cancer. Comen EA; Robson M Cancer J; 2010; 16(1):48-52. PubMed ID: 20164690 [TBL] [Abstract][Full Text] [Related]
16. Synthetic lethal interactions between EGFR and PARP inhibition in human triple negative breast cancer cells. Nowsheen S; Cooper T; Stanley JA; Yang ES PLoS One; 2012; 7(10):e46614. PubMed ID: 23071597 [TBL] [Abstract][Full Text] [Related]
17. PARP-1 expression in breast cancer including BRCA1-associated, triple negative and basal-like tumors: possible implications for PARP-1 inhibitor therapy. Domagala P; Huzarski T; Lubinski J; Gugala K; Domagala W Breast Cancer Res Treat; 2011 Jun; 127(3):861-9. PubMed ID: 21409392 [TBL] [Abstract][Full Text] [Related]
18. The triple-negative subtype: new ideas for the poorest prognosis breast cancer. Curigliano G; Goldhirsch A J Natl Cancer Inst Monogr; 2011; 2011(43):108-10. PubMed ID: 22043054 [TBL] [Abstract][Full Text] [Related]
19. Targeting triple negative breast cancer: is p53 the answer? Turner N; Moretti E; Siclari O; Migliaccio I; Santarpia L; D'Incalci M; Piccolo S; Veronesi A; Zambelli A; Del Sal G; Di Leo A Cancer Treat Rev; 2013 Aug; 39(5):541-50. PubMed ID: 23321033 [TBL] [Abstract][Full Text] [Related]
20. Clinical trials in triple negative breast cancer. Reeder-Hayes KE; Carey LA; Sikov WM Breast Dis; 2010; 32(1-2):123-36. PubMed ID: 21778571 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]